CIK 0001000694
- Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222816046
- Phone
- +1 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-18 | MCMANUS MICHAEL A JR Director | Exercise or conversion · Stock Option (Right to Buy) | −4,000 | 0 | ||
| 2020-08-18 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion | +1,000 | $50.00 | $50K | 1,275 |
| 2020-08-18 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion | +7,499 | $36.60 | $274K | 8,774 |
| 2020-08-18 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion | +2,499 | $91.00 | $227K | 11,273 |
| 2020-08-18 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion | +11,249 | $99.80 | $1.1M | 22,522 |
| 2020-08-18 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion | +393 | $27.00 | $11K | 22,915 |
| 2020-08-18 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion | +1,952 | $27.00 | $53K | 24,867 |
| 2020-08-18 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion | +13,322 | $27.60 | $368K | 38,189 |
| 2020-08-18 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion | +8,328 | $46.00 | $383K | 46,517 |
| 2020-08-18 | Herrmann John A III EVP, Chief Legal Officer | Sale | −24,594 | $143.92 | $3.5M | 21,923 |
| 2020-08-18 | Herrmann John A III EVP, Chief Legal Officer | Sale | −21,648 | $144.79 | $3.1M | 275 |
| 2020-08-18 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) | −1,000 | 0 | ||
| 2020-08-18 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) | −7,499 | 0 | ||
| 2020-08-18 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) | −2,499 | 0 | ||
| 2020-08-18 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) | −11,249 | 0 | ||
| 2020-08-18 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) | −393 | 394 | ||
| 2020-08-18 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) | −1,952 | 4,298 | ||
| 2020-08-18 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) | −13,322 | 6,677 | ||
| 2020-08-18 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) | −8,328 | 11,671 | ||
| 2020-08-18 | Glenn Gregory M President, R&D | Exercise or conversion | +3,200 | $50.00 | $160K | 5,039 |
Page 83 of 87 · 1,734 trades